Depression in primary Sjögren's syndrome: a systematic review and meta-analysis

• Published in: Psychology, health & medicine Vol. 23; no. 2; pp. 198 - 209
• Main Authors: Cui, Yafei, Li, Lin, Yin, Rulan, Zhao, Qian, Chen, Shengnan, Zhang, Qiuxiang, Shen, Biyu
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 07.02.2018; Taylor & Francis Ltd
• Subjects: Clinical assessment; Comorbidity; Depression; Depressive Disorder - epidemiology; Early intervention; Humans; Mental depression; Meta-analysis; primary Sjögren's syndrome; Quality of life; Severity; Sjogren's Syndrome - epidemiology; Systematic review; Uncertainty; meta-analysis; Depression; primary Sjögren’s syndrome; systematic review
• ISSN: 1354-8506; 1465-3966
• DOI: 10.1080/13548506.2017.1339895

There is substantial uncertainty regarding the prevalence of depression in Primary Sjögren's syndrome (pSS). We conducted a systematic review aiming to evaluate the association of pSS with depression. PubMed, Web of Science, VIP, CNKI and Wanfang database were searched to find the published literatures (from these databases established to October 2016). Studies were screened according to inclusion and exclusion criteria and the qualities of included studies were evaluated. The data was analyzed using Revman5.2 software. A total of 12 studies including 1917 patients were eligible for inclusion in the systematic review and meta-analysis. In this meta-analysis, Severity of depression was assessed using psychometric measures, such as PHQ-9; HADS; CES-D; Zung depression scale and BDI. The result revealed that pSS was associated with an increased prevalence of depression (summary odds ratio (OR) = 5.36, 95% CI: 4.05-7.09, P < 0.01). The depression score in pSS patients (standardized mean difference (SMD) = 1.47, 95% CI: 0.81-2.12, P < 0.01) were higher than in the control group. Depression is highly prevalent in pSS than in healthy controls. Early recognition and appropriate intervention are therefore essential to reduce the negative impact of depression on the patient's quality of life and outcome of their disease.